{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T12:37:10Z","timestamp":1742647030279,"version":"3.30.0"},"reference-count":36,"publisher":"The Japanese Society for Medical Mycology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Mycology Journal"],"published-print":{"date-parts":[[2024,10,31]]},"DOI":"10.3314\/mmj.24.008","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T22:13:00Z","timestamp":1732918380000},"page":"99-102","source":"Crossref","is-referenced-by-count":1,"title":["Overview of Fungi Classified as Risk Group 3 by the Japanese Society for Medical Mycology"],"prefix":"10.3314","volume":"65","author":[{"given":"Masato","family":"Tashiro","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences"},{"name":"Infection Control and Education Center, Nagasaki University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Takazono","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences"},{"name":"Department of Respiratory Medicine, Nagasaki University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Izumikawa","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences"},{"name":"Infection Control and Education Center, Nagasaki University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1842","reference":[{"key":"1","unstructured":"1) World Health Organization: Laboratory biosafety manual, 3rd edition: World Health Organization; 2004. Available from: https:\/\/www.who.int\/publication\/i\/item\/9241546506."},{"key":"2","unstructured":"2) Advisory Committee on Dangerous Pathogens (ACDP): The approved list of biological agents, 5th ediiton. UK: Health and Safety Executive (HSE); 2023."},{"key":"3","unstructured":"3) Ichikawa T, Kawai Y, Satoh K, Murayama S, Yaguchi T: Biosafety level classification of fungi. Nihon Ishinkin Gakkai Zasshi 63: 99–102, 2022. [Article in Japanese]"},{"key":"4","unstructured":"4) World Health Organization: Laboratory biosafety manual, 4th edition: World Health Organization; 2020. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240011311."},{"key":"5","unstructured":"5) Public Health Agency of Canada, Government of Canada: Pathogen Safety Data Sheets [Internet]. [cited 2024-04-21]. Available from: https:\/\/www.canada.ca\/en\/public-health\/services\/laboratory-biosafety-biosecurity\/pathogen-safety-data-sheets-risk-assessment.html."},{"key":"6","unstructured":"6) Meechan PJ, Potts J: Biosafety in microbiological and biomedical laboratories, 6th edition. USA: Centers for Disease Control Prevention, National Institutes of Health; 2020. Available from: https:\/\/stacks.cdc.gov\/view\/cdc\/97733."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Fang W, Washington L, Kumar N: Imaging manifestations of blastomycosis: a pulmonary infection with potential dissemination. Radiographics 27: 641–55, 2007.","DOI":"10.1148\/rg.273065122"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Linder KA, Kauffman CA, Miceli MH: Blastomycosis: a review of mycological and clinical aspects. J Fungi (Basel) 9: 117, 2023.","DOI":"10.3390\/jof9010117"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Pullen MF, Alpern JD, Bahr NC: Blastomycosis-some progress but still much to learn. J Fungi (Basel) 8: 824, 2022.","DOI":"10.3390\/jof8080824"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Ashraf N, Kubat RC, Poplin V, Adenis AA, Denning DW, Wright L, et al: Re-drawing the maps for endemic mycoses. Mycopathologia 185: 843–65, 2020.","DOI":"10.1007\/s11046-020-00431-2"},{"key":"11","unstructured":"11) Thompson GR 3rd, Le T, Chindamporn A, Kauffman CA, Alastruey-Izquierdo A, Ampel NM, et al: Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology. Lancet Infect Dis 21: e364–e74, 2021."},{"key":"12","unstructured":"12) Collins CH, Kennedy DA: Laboratory-acquired infections. Laboratory-acquired Infections, 4th ed, p. 31, Butterworth-Heinemann, Woburn, MA, 1999."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Schell WA: Mycotic agent of human disease. Biological Safety: Principles and Practices 4th ed (Fleming DO, Hunt DL, eds), pp. 163–78, ASM Press, Washington, D.C., 2006.","DOI":"10.1128\/9781555815899.ch8"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Ganesan V, Hallur V, Velvizhi S, Rajendran T: Cerebral phaeohyphomycosis due to Cladophialophora bantiana<\/i>: case report and systematic review of cases. Infection 52: 313–21, 2024.","DOI":"10.1007\/s15010-023-02126-4"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Chowdhary A, Meis JF, Guarro J, de Hoog GS, Kathuria S, Arendrup MC, et al; European Society of Clinical M, Infectious Diseases Fungal Infection Study G, European Confederation of Medical M: ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi. Clin Microbiol Infect 20 (Suppl 3): 47–75, 2014.","DOI":"10.1111\/1469-0691.12569"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) de Hoog GS, Gueho E, Masclaux F, Gerrits van den Ende AH, Kwon-Chung KJ, McGinnis MR: Nutritional physiology and taxonomy of human-pathogenic Cladosporium-Xylohypha species. J Med Vet Mycol 33: 339–47, 1995.","DOI":"10.1080\/02681219580000661"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Chakrabarti A, Kaur H, Rudramurthy SM, Appannanavar SB, Patel A, Mukherjee KK, et al: Brain abscess due to Cladophialophora bantiana<\/i>: a review of 124 cases. Med Mycol 54: 111–9, 2016.","DOI":"10.1093\/mmy\/myv091"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Kirkland TN, Stevens DA, Hung CY, Beyhan S, Taylor JW, Shubitz LF, et al: Coccidioides<\/i> species: a review of basic research: 2022. J Fungi (Basel) 8: 859, 2022.","DOI":"10.3390\/jof8080859"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) McHardy IH, Barker B, Thompson GR 3rd: Review of clinical and laboratory diagnostics for coccidioidomycosis. J Clin Microbiol 61: e0158122, 2023.","DOI":"10.1128\/jcm.01581-22"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Kirkland TN, Hung CY, Shubitz LF, Beyhan S, Fierer J: The host response to coccidioidomycosis. J Fungi (Basel) 10: 173, 2024.","DOI":"10.3390\/jof10030173"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Reyes-Montes MDR, León-García AA, Frías-De-León MG, Acosta-Altamirano G, Sánchez-Saavedra EP, Victoriano-Pastelín I, et al: Clinical cases of coccidioidomycosis in the Americas in the period 1950-2021: epidemiology data, diagnosis, and treatment. Life (Basel) 13: 2109, 2023.","DOI":"10.3390\/life13112109"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Bays DJ, Thompson GR 3rd: Coccidioidomycosis. Infect Dis Clin North Am 35: 453–69, 2021.","DOI":"10.1016\/j.idc.2021.03.010"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Abad CLR, Razonable RR: Donor-derived endemic mycoses after solid organ transplantation: a review of reported cases. Clin Transplant 38: e15199, 2024.","DOI":"10.1111\/ctr.15199"},{"key":"24","unstructured":"24) Pike RM: Laboratory-associated infections: summary and analysis of 3921 cases. Health Lab Sci 13: 105–14, 1976."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Valdez AF, Miranda DZ, Guimarães AJ, Nimrichter L, Nosanchuk JD: Pathogenicity & virulence of Histoplasma capsulatum<\/i>: a multifaceted organism adapted to intracellular environments. Virulence 13: 1900–19, 2022.","DOI":"10.1080\/21505594.2022.2137987"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Toscanini MA, Nusblat AD, Cuestas ML: Diagnosis of histoplasmosis: current status and perspectives. Appl Microbiol Biotechnol 105: 1837–59, 2021.","DOI":"10.1007\/s00253-021-11170-9"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Knox KS, Hage CA: Histoplasmosis. Proc Am Thorac Soc 7: 169–72, 2010.","DOI":"10.1513\/pats.200907-069AL"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) de Perio MA, Benedict K, Williams SL, Niemeier-Walsh C, Green BJ, Coffey C, et al: Occupational histoplasmosis: epidemiology and prevention measures. J Fungi (Basel) 7: 510, 2021.","DOI":"10.3390\/jof7070510"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Sewell DL: Laboratory-associated infections and biosafety. Clin Microbiol Rev 8: 389–405, 1995.","DOI":"10.1128\/CMR.8.3.389"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Pike RM: Laboratory-associated infections: incidence, fatalities, causes, and prevention. Annu Rev Microbiol 33: 41–66, 1979.","DOI":"10.1146\/annurev.mi.33.100179.000353"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Jabeen K, Farooqi J, Zafar A, Jamil B, Mahmood SF, Ali F, et al: Rhinocladiella mackenziei<\/i> as an emerging cause of cerebral phaeohyphomycosis in Pakistan: a case series. Clin Infect Dis 52: 213–7, 2011.","DOI":"10.1093\/cid\/ciq114"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Taj-Aldeen SJ, Almaslamani M, Alkhalf A, Al Bozom I, Romanelli AM, Wickes BL, et al: Cerebral phaeohyphomycosis due to Rhinocladiella mackenziei<\/i> (formerly Ramichloridium mackenziei<\/i>): a taxonomic update and review of the literature. Med Mycol 48: 546–56, 2010.","DOI":"10.3109\/13693780903383914"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Mohammadi R, Mohammadi A, Ashtari F, Khorvash F, Hakamifard A, Vaezi A, et al: Cerebral phaeohyphomycosis due to Rhinocladiella mackenziei<\/i> in Persian Gulf region: a case and review. Mycoses 61: 261–5, 2018.","DOI":"10.1111\/myc.12734"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Kucukkaya IC, Gulsever CI, Dolas I, Genc GE, Kuskucu MA, Sabanci PA, et al: First case of Rhinocladiella mackenziei<\/i> brain abscess in Turkey: case report and review of the literature. Mycoses 66: 755–66, 2023.","DOI":"10.1111\/myc.13601"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Al-Tawfiq JA, Boukhamseen A: Cerebral phaeohyphomycosis due to Rhinocladiella mackenziei<\/i> (formerly Ramichloridium mackenziei<\/i>): case presentation and literature review. J Infect Public Health 4: 96–102, 2011.","DOI":"10.1016\/j.jiph.2011.01.001"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Alabdely MH, Alolayan AS, Almaghrabi RS, Al-Abdely HM: Cerebral phaeohyphomycosis at a tertiary healthcare center in Saudi Arabia. Neurosciences (Riyadh) 28: 136–42, 2023.","DOI":"10.17712\/nsj.2023.2.20220118"}],"container-title":["Medical Mycology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mmj\/65\/4\/65_99\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T04:56:38Z","timestamp":1732942598000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mmj\/65\/4\/65_99\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,31]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.3314\/mmj.24.008","relation":{},"ISSN":["2185-6486","2186-165X"],"issn-type":[{"value":"2185-6486","type":"print"},{"value":"2186-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,31]]}}}